Related Experiment Video
Updated: Apr 3, 2026
08:42
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
8.9K
Autism Spectrum Disorder and Epilepsy: Two Sides of the Same Coin?
Shafali Spurling Jeste1, Roberto Tuchman2
1UCLA David Geffen School of Medicine, University of California, Los Angeles, CA, USA SJeste@mednet.ucla.edu.
Journal of Child Neurology
|September 17, 2015
Summary
Autism spectrum disorder and epilepsy frequently co-occur. This review explores their relationship, focusing on clinical features, genetic links, and using electrophysiology for better patient stratification and intervention targets.
Area of Science:
- Neuroscience
- Genetics
- Clinical Medicine
Background:
- Autism spectrum disorder (ASD) and epilepsy are highly comorbid conditions.
- Understanding the interplay between ASD, epilepsy, and intellectual disability is crucial.
- Existing research presents unresolved questions regarding their temporal relationship and causal mechanisms.
Purpose of the Study:
- To review unresolved questions concerning the temporal relationship, causal mechanisms, and clinical stratification of ASD-epilepsy comorbidity.
- To highlight the interplay between ASD, epilepsy, and intellectual disability.
- To explore the utility of electrophysiology as a biomarker for clinical stratification and outcome prediction.
Main Methods:
- Review of existing literature on ASD and epilepsy comorbidity.
- Clinical characterization of children with ASD and epilepsy.
- Analysis of genetic variants associated with synaptic dysfunction.
- Evaluation of electrophysiology as a quantitative biomarker.
Main Results:
- Distinctive clinical phenotypes emerge in children with comorbid ASD and epilepsy.
- Convergent genetic pathways involving synaptic dysfunction are identified.
- Electrophysiological patterns may aid in defining biologically relevant subgroups within ASD.
Conclusions:
- The comorbidity of ASD and epilepsy offers insights into shared etiological pathways.
- Electrophysiology shows promise as a biomarker for stratifying patients and predicting outcomes.
- Identifying distinct subgroups can guide the development of targeted interventions for ASD-epilepsy.
Related Concept Videos
01:19Autism Spectrum Disorder
1.8K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.8K
01:24Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
01:13Seizures: Classification
2.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K